Blueberry Sleep Randomized Trial: What the Evidence Says

Quick Answer

Blueberry Sleep Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are randomized trial, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 2 randomized trial.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Globally, hypertension is renowned as the leading risk factor for cardiovascular disease morbidity and mortality. [Sinclair Jonathan (2026); evidence level 2]
• High blood pressure ranks first among modifiable risk factors attributable to cardiovascular disease aetiology, accounting for the largest proportion of coronary heart disease, heart failure, and stroke events. [Sinclair Jonathan (2026); evidence level 2]
• Tart cherry juice, rich in melatonin, has been linked to improved sleep duration and quality. [Shoji Kentaro (2026); evidence level 2]
• Given this background, our previous interventional trial served as a pilot study to explore the sleep-improving effects of hyperoside, a flavonoid abundantly found in blueberry leaves. [Shoji Kentaro (2026); evidence level 2]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is trial evidence in the current set, but population and intervention details still matter. For blueberry sleep randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Sinclair Jonathan (2026). Effects of peppermint ( Mentha x piperita L.) oil on cardiometabolic outcomes in patients with pre- and stage 1 hypertension: A placebo randomized controlled trial. DOI: 10.1371/journal.pone.0344538. PMCID: PMC13105356. PMID: 42024666. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13105356/
• Shoji Kentaro (2026). Hyperoside-Rich Blueberry Leaf Tea Improves Sleep Continuity in Adults with Poor Sleep: A Two-Week Randomized Double-Blind Controlled Trial. DOI: 10.3390/nu18030453. PMCID: PMC12899917. PMID: 41683277. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12899917/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.